课题基金 / 基金详情

CONTINUOUS INFUSION PROLEUKIN (ALDESLEUKIN) CHIRON RECOMBINANT INTERLEUKIN

CONTINUOUS INFUSION PROLEUKIN (ALDESLEUKIN) CHIRON RECOMBINANT INTERLEUKIN
持续输注白介素原 (ALDESLEUKIN) CHIRON 重组白细胞介素
批准号：
6279576
负责人：
RONALD T. MITSUYASU
金额：
$1.77万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6279576
关键词：
AIDS therapy HIV infections antiviral agents clinical research clinical trials combination chemotherapy dosage drug administration rate /duration drug screening /evaluation human subject human therapy evaluation immunotherapy injection /infusion interleukin 2 recombinant proteins

项目摘要

项目成果

RONALD T. MITSUYASU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary objective of this study is to evaluate the effectiveness of continuous infusion recombitant interleukin-2(IL-2) with antiretroviral therapy compared to antiretroviral therapy alone in patients with HIV infection and CD4 counts between 100-300 cells/mm3. The safety and tolerance of the three dosing regiments of interleukin-2 will be evaluated in order to determine the optimal regimen which may be effective for long term administration of IL-2 in this advanced stage with HIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
South American Prevention of HIV Research Training Program (SAPHIR)
South American Prevention of HIV Research Training Program (SAPHIR)
海外基金